What Happened?
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ: RGEN) jumped 7.3% in the morning session after the company reported first-quarter 2026 financial results that included a significant earnings beat and an increased full-year profit outlook.
Delving into the results, Repligen's revenue grew 14.8% year on year to $194.3 million, topping expectations. The key driver for investors appeared to be profitability, as adjusted earnings per share of $0.48 significantly surpassed Wall Street's estimate of $0.38.
Bolstering investor confidence, the company also raised its full-year guidance for adjusted earnings per share to a midpoint of $2.01. This positive profit outlook helped overshadow a slight lowering of the company's full-year revenue forecast.
Is now the time to buy Repligen? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Repligen’s shares are quite volatile and have had 17 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 13 days ago when the stock dropped 5.3% on the news that an SEC filing revealed that the company's Chief Executive Officer, Olivier Loeillot, sold company stock.
According to the filing, Loeillot sold 3,832 shares for a total value of $536,480. The transaction was carried out under a Rule 10b5-1 trading plan, which was put in place in August 2025. These plans allow company insiders to sell a predetermined number of shares at a predetermined time. Even though the sale was planned, a significant sale by a top executive can still concern investors. After the transaction, Loeillot continued to hold 54,246 shares of Repligen.
Repligen is down 22.5% since the beginning of the year, and at $127.31 per share, it is trading 26.1% below its 52-week high of $172.26 from January 2026. Investors who bought $1,000 worth of Repligen’s shares 5 years ago would now be looking at only $653.51.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.
